However, PPARα activation is also responsible for the production of fibroblast growth factor 21 (FGF21) [75], whose signaling plays a key role in the progression of NAFLD, due to a direct crosstalk with PXR and CYP3A4-related pathways [63,71]. This evidence concerns the gene NR1I2 and metabolic dysfunction-associated steatotic liver disease.